BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 24744457)

  • 21. Role of microRNAs in gynecological pathology.
    Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
    Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of exosomal microRNAs in lung cancer biology and clinical applications.
    Hu C; Meiners S; Lukas C; Stathopoulos GT; Chen J
    Cell Prolif; 2020 Jun; 53(6):e12828. PubMed ID: 32391938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs: Key Regulators in Lung Cancer.
    El Founini Y; Chaoui I; Dehbi H; El Mzibri M; Abounader R; Guessous F
    Microrna; 2021; 10(2):109-122. PubMed ID: 34047262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents.
    Qian B; Nag SA; Su Y; Voruganti S; Qin JJ; Zhang R; Cho WC
    Curr Cancer Drug Targets; 2013 Jun; 13(5):519-41. PubMed ID: 23597193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
    Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
    Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. YY1-mediated overexpression of long noncoding RNA MCM3AP-AS1 accelerates angiogenesis and progression in lung cancer by targeting miR-340-5p/KPNA4 axis.
    Li X; Yu M; Yang C
    J Cell Biochem; 2020 Mar; 121(3):2258-2267. PubMed ID: 31693222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathological role of microRNAs and inflammation in colon carcinogenesis.
    Zhang L; Fan XM
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):174-9. PubMed ID: 25154001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA function in cancer: oncogene or a tumor suppressor?
    Shenouda SK; Alahari SK
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):369-78. PubMed ID: 20012925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model.
    He RQ; Li XJ; Liang L; Xie Y; Luo DZ; Ma J; Peng ZG; Hu XH; Chen G
    BMC Cancer; 2017 Sep; 17(1):655. PubMed ID: 28927388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNAs and lung cancer: tumors and 22-mers.
    Du L; Pertsemlidis A
    Cancer Metastasis Rev; 2010 Mar; 29(1):109-22. PubMed ID: 20130964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation.
    Ishimoto T; Baba H; Izumi D; Sugihara H; Kurashige J; Iwatsuki M; Tan P
    Int J Cancer; 2016 Mar; 138(6):1337-49. PubMed ID: 26041092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNAs and cancer: role in tumorigenesis, patient classification and therapy.
    Hernando E
    Clin Transl Oncol; 2007 Mar; 9(3):155-60. PubMed ID: 17403626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-coding RNA profile in lung cancer.
    Ghafouri-Fard S; Shoorei H; Branicki W; Taheri M
    Exp Mol Pathol; 2020 Jun; 114():104411. PubMed ID: 32112788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of microRNAs in lung cancer biology and therapy.
    Liu X; Sempere LF; Guo Y; Korc M; Kauppinen S; Freemantle SJ; Dmitrovsky E
    Transl Res; 2011 Apr; 157(4):200-8. PubMed ID: 21420030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs as novel regulators of angiogenesis.
    Suárez Y; Sessa WC
    Circ Res; 2009 Feb; 104(4):442-54. PubMed ID: 19246688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance and Applications in Human Triple-Negative Breast Cancer.
    Ding L; Gu H; Xiong X; Ao H; Cao J; Lin W; Yu M; Lin J; Cui Q
    Cells; 2019 Nov; 8(12):. PubMed ID: 31766744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs: novel regulators in the hallmarks of human cancer.
    Ruan K; Fang X; Ouyang G
    Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs: master regulators of drug resistance, stemness, and metastasis.
    Raza U; Zhang JD; Sahin O
    J Mol Med (Berl); 2014 Apr; 92(4):321-36. PubMed ID: 24509937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.